Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
5.65
-0.14 (-2.42%)
Mar 20, 2026, 4:00 PM EDT - Market closed
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $412.38 million as of March 20, 2026. Its market cap has increased by 343.67% in one year.
Market Cap
412.38M
Enterprise Value
298.07M
1-Year Change
343.67%
Ranking
Category
Stock Price
$5.65
Market Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has increased from $271.36M to $412.38M, an increase of 51.97%. That is a compound annual growth rate of 19.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 412.38M | -43.10% |
| Dec 31, 2025 | 724.76M | 232.99% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
| Nov 3, 2023 | 271.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Maravai LifeSciences Holdings | 436.22M |
| Century Therapeutics | 434.93M |
| Altimmune | 434.43M |
| Entrada Therapeutics | 433.00M |
| Vanda Pharmaceuticals | 420.85M |
| Neumora Therapeutics | 419.39M |
| REGENXBIO | 418.07M |
| Aura Biosciences | 415.95M |